Ghanaian and Novartis researchers build scientific bridges
Emerging markets in Africa are gearing up for clinical research. Learn how Novartis is working with Ghana and Kenya to build research capacity.
Feb 08, 2013
During the summer in 2012, six science research fellows from Ghana visited NIBR Cambridge working closely with NIBR researchers across various disease areas and scientific platforms.
Through fellowships and internships, students of research, medicine, nursing or pharmacy from developing nations can gain practical knowledge in the discovery and development of new therapeutic drugs, and the delivery of medical care.
“I knew my students could benefit greatly from the visit to NIBR in Cambridge, and they all had wonderful things to say about their laboratory experiences," says Karen Duca, Associate Professor, Clinical and Medical Biochemistry and Biotechnology, Kwame Nkrumah University of Science and Technology (KNUST) in Kumasi, Ghana.
Their experience catalyzed the idea for NIBR scientists to visit Ghana later in the year to conduct educational workshops for the wider KNUST university research community
"Through these workshops, many of the junior scientists who couldn't go to Cambridge were exposed to world-class drug discovery training, and they saw what their potential could be and a path to achieve it," says Karen.
Building connections between Novartis and African scientists and medical communities is critical to solving major health problems that impact millions of people in Africa.